1
|
Matsuzaki T, Eguchi K, Nagao N, Tsuji S, Aramaki T, Terada K, Iwatsu S, Tokimura I, Kamo Y, Oda H, Kinoshita N, Miyaaki H, Taura N, Ichikawa T, Kawakami A, Nakao K, Ueki Y. Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study. Mod Rheumatol 2018; 28:808-813. [PMID: 29256314 DOI: 10.1080/14397595.2017.1419842] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
OBJECTIVES This study aimed to investigate the frequency of hepatitis B virus (HBV) reactivation in patients with rheumatoid arthritis (RA) and to verify the guidelines relating to HBV reactivation in Japan. METHODS We retrospectively investigated 1351 RA patients who were treated with antirheumatic drugs at our hospital. RESULTS Fifty patients (3.7%; 50/1351) were determined to be HBV carriers and 360 patients (26.7%; 360/1351) had resolved infections. HBV reactivation occurred in six cases (1.7%: 6/360) with resolved infections, of whom, two cases (0.6%; 2/360) developed de novo HBV infections. Eleven of the patients who were HBV carriers received a nucleoside analogue (NA) prophylactically. In all of the cases, the HBV-DNA levels became undetectable and the patients' liver function normalized. Sixteen patients, who had lower titers of the HBV surface antigen and undetectable HBV-DNA levels, did not show HBV reactivation in the absence of NA therapy. CONCLUSIONS The results from this study suggest that HBV reactivation might not be so frequent among RA patients, and that reliable indicators for prescribing a NA should be clarified for RA patients.
Collapse
Affiliation(s)
| | - Katsumi Eguchi
- b Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Natsumi Nagao
- b Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Sousuke Tsuji
- b Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Toshiyuki Aramaki
- b Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Kaoru Terada
- b Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Shinichi Iwatsu
- a Digestive Endoscopy Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Ikuko Tokimura
- a Digestive Endoscopy Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Yasuhiro Kamo
- a Digestive Endoscopy Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Hidetoshi Oda
- a Digestive Endoscopy Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Noboru Kinoshita
- a Digestive Endoscopy Center, Sasebo Chuo Hospital , Nagasaki , Japan
| | - Hisamitsu Miyaaki
- c Department of Gastroenterology and Hepatology , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , Japan
| | - Naota Taura
- c Department of Gastroenterology and Hepatology , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , Japan
| | - Tatsuki Ichikawa
- c Department of Gastroenterology and Hepatology , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , Japan
| | - Atsushi Kawakami
- d Department of Immunology and Rheumatology , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , Japan
| | - Kazuhiko Nakao
- c Department of Gastroenterology and Hepatology , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , Japan
| | - Yukitaka Ueki
- b Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Nagasaki , Japan
| |
Collapse
|